An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.

Cystic fibrosis is one of the most commonly tested autosomal recessive disorders in the United States. Clinical cystic fibrosis is associated with mutations in the CFTR gene, of which the most ...

Further studies are needed to validate our findings. Cystic fibrosis (CF) is an autosomal recessive genetic disorder, caused by mutations in the gene which encodes the cystic fibrosis transmembrane ...

1 Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts, USA 2 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA 3 Harvard Medical School, ...

CF affects every racial and ethnic group and is currently estimated to afflict more than 30,000 individuals in the United States and at least 100,000 people worldwide. 1,2,5 1. Shteinberg M, Haq IJ, ...

The management of CF has been changing drastically over the last few years, especially after the introduction of CFTR modulators. Currently, 188,336 people have the disease in 96 countries, but only ...

Several years ago, my dad was diagnosed with pulmonary fibrosis. The news was a shock. At 84 years old, Daddy had been dedicated to his physical health for decades. He played tennis twice a week, ate ...

Sophie Pierce will be the first person with cystic fibrosis to do just that, travelling from Lanzarote to Antigua. A historic achievement when you consider what she's been through and when ...

University of South Florida pulmonologist Dr. Jose Herazo-Maya has focused his career on researching treatments for pulmonary fibrosis, a devastating and deadly lung disease. Pulmonary fibrosis in ...

only one is needed to prevent cystic fibrosis. CF develops when neither gene works normally and therefore has autosomal recessive inheritance. CF is most common among Caucasians; one in 25 people ...